Scientific Letters
Vol. 15 No. 1 (2023): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience.
Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: October 11, 2022
Accepted: December 18, 2022
Accepted: December 18, 2022
1273
Views
909
Downloads
379
HTML
Authors
No abstract
Downloads
Download data is not yet available.
Citations
How to Cite
“Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. : Coagulopathy in APL treated with ATRA and Arsenic Trioxide”. (2023) Mediterranean Journal of Hematology and Infectious Diseases, 15(1), p. e2023009. doi:10.4084/MJHID.2023.009.
Copyright (c) 2022 Francesco Autore, Patrizia Chiusolo, Federica Sora', Luca Laurenti, Livio Pagano, Andrea Bacigalupo, Valerio De Stefano, Simona Sica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
